Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia.
Jain P, Klotz J, Dunavin N, Lu K, Koklanaris E, Draper D, Superata J, Chinian F, Yu Q, Keyvanfar K, Wong S, Muranski P, Barrett AJ, Ito S, Battiwalla M.
Jain P, et al. Among authors: battiwalla m.
Leuk Res Rep. 2017 Apr 13;7:40-44. doi: 10.1016/j.lrr.2017.04.003. eCollection 2017.
Leuk Res Rep. 2017.
PMID: 28462085
Free PMC article.